Medication info
Esomeprazole Magnesium 20 mg (Esomeprazole Magnesium Trihydrate)

Esomeprazole Magnesium 20 mg (Esomeprazole Magnesium Trihydrate)

Prescription medicationTabletOral · Intravenous injection
Ingredient · strength
Esomeprazole Magnesium Dihydrate›21.69mg / 1 tablet
Manufacturer / importer
iWorld Pharmaceutical Co., Ltd.
Appearance
Pale pink rectangular film-coated tablet
Packaging
28 tablets (14 tablets/Alu-AluX2)
Approval status
Active

MFDS item code 201604346 · Approved 2016.07.14 · Insurance code 669604800

Summary

Main use
Treatment of acid-related disorders (e.g., reflux disease), ulcers and gastrointestinal symptoms, and Helicobacter pylori eradication
Who uses it
Adults · Children
Adult dosage
This medicine should be swallowed with liquid such as water; do not chew or crush it. Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, on-demand administration is not recommended for controlling recurring symptoms. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. 20 mg once daily. The treatment duration is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg daily. Doses above 80 mg daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.
Children's dosage
Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older: Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. Children under 12 years: There is no experience with administration of this medication to children under 12 years.

Ingredients

Manufacturer
iWorld Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., reflux disease), ulcers and gastrointestinal symptoms, and Helicobacter pylori eradication

  • Gastroesophageal reflux disease
  • erosive reflux esophagitis
  • esophagitis
  • duodenal ulcer
  • peptic ulcer
  • upper gastrointestinal pain
  • upper gastrointestinal discomfort
  • upper gastrointestinal burning sensation
  • gastric ulcer
  • duodenal ulcer
  • Zollinger-Ellison syndrome
  • gastric ulcer rebleeding
View approved original text

This medication is used for the treatment of gastroesophageal reflux disease, erosive reflux esophagitis, and for long-term maintenance therapy to prevent recurrence in patients with esophagitis. It is also effective for the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers in patients with Helicobacter pylori infection. It helps in the short-term treatment of upper gastrointestinal symptoms related to the use of non-steroidal anti-inflammatory drugs (both non-selective and selective COX-2) and in the treatment and prevention of gastric ulcers. Additionally, it is widely used for the treatment of Zollinger-Ellison syndrome and maintenance therapy after inducing prevention of rebleeding from gastric or duodenal ulcers. It is used to improve symptoms and diseases related to various gastrointestinal disorders.

Dosage and Administration

Adult dosage

This medicine should be swallowed with liquid such as water; do not chew or crush it. Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. 20 mg once daily 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. In adults, 20 mg may be administered once daily as needed. For patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment, on-demand administration is not recommended for controlling recurring symptoms. Administer this medicine 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. 20 mg once daily. The treatment duration is 4∼8 weeks. 20 mg once daily. The recommended initial dose is 40 mg twice daily. Thereafter, the dose should be adjusted individually, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with a dose of 80 ∼ 160 mg daily. Doses above 80 mg daily should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following intravenous treatment to prevent rebleeding due to gastric or duodenal ulcers. No dose adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine should not exceed 20 mg. No dose adjustment is necessary.

Children's dosage

Adolescents aged 12 years and older: Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. Adolescents aged 12 years and older: Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Adolescents aged 12 years and older: Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. Children under 12 years: There is no experience with administration of this medication to children under 12 years.

Precautions

This medication should not be used in patients who are allergic or have experienced hypersensitivity to certain ingredients. Special caution is needed for those with hypersensitivity to benzimidazoles, penicillin, or macrolide antibiotics. It should not be administered to patients taking specific cardiovascular medications or those with a history of myocardial infarction, or to nursing mothers. This medication contains the dye tartrazine; patients allergic to this ingredient should use it cautiously. During usage, various side effects such as headache, dizziness, abdominal pain, diarrhea, and skin rashes may appear, and if symptoms persist or worsen, consulting a physician is necessary. Long-term use requires regular tests such as blood tests, and there may be increased risk of fractures or hypomagnesemia, so caution is needed. This drug can interact with other medications, so if you are taking any medications, you must inform your healthcare provider. Special care is needed when used in conjunction with antiviral agents, antibiotics, or anticoagulants due to potential changes in drug concentration and risk of side effects. During pregnancy, safety has not been fully established, so it should only be used cautiously when necessary, and it is advisable to avoid use during breastfeeding. In the case of overdose, there is no specific antidote, and since it is not removed by dialysis, appropriate treatment should be administered in a hospital immediately. Finally, keep this medication out of reach of children and do not transfer it to another container.

Side effects

Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Liddle syndrome, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile diarrhea, abdominal distention, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, rigidity, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, indigestion, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorder, pharyngeal disorder, rectal disorder, gastrointestinal symptoms, increased serum gastrin, tongue disorder, tongue swelling, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonia, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorder, tremor, dizziness, visual field defect, paresthesia, drowsiness, dysmenorrhea, menstrual disorder, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, altered olfaction, loss of taste, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, discoid lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, increased creatine kinase, elevated serum myoglobin, increased urinary myoglobin, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 1°C and 30°C room temperature.

Appearance and packaging

Appearance

Pale pink rectangular film-coated tablet

Package unit

28 tablets (14 tablets/Alu-AluX2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.